Phosphorylation of the Retinoblastoma protein (RB) on serine-807 is required for association with Bax

Cell Cycle

Volumn 13, Issue 22, 2014, Pages 3611-3617

  Antonucci, Lisa A ^a   Egger, Jacklynn V ^a   Krucher, Nancy A ^a  

^a PACE UNIVERSITY   (United States)

Author keywords

Apoptosis; Bax; Phosphatase; Rb phosphorylation; Retinoblastoma protein

Indexed keywords

PROTEIN BAX; RETINOBLASTOMA PROTEIN; SERINE; PROTEIN BINDING; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DOWN REGULATION; IMMUNOPRECIPITATION; IN VITRO STUDY; MITOCHONDRION; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; BINDING SITE; CELL DIFFERENTIATION; CELL PROLIFERATION; GENETICS; HUMAN; MCF 7 CELL LINE; METABOLISM; PHOSPHORYLATION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BINDING SITES; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMANS; MCF-7 CELLS; PHOSPHORYLATION; PROTEIN BINDING; RETINOBLASTOMA PROTEIN; RNA, SMALL INTERFERING; SERINE;

EID: 84919884352     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/15384101.2014.964093     Document Type: Article

References (38)

1. Burkhart DL, Sage J. Cellular mechanism of tumor suppression by the retinoblastoma gene. Nat Rev Cancer 2008; 8:671-82; PMID:18650841; http://dx.doi. org/10.1038/nrc2399
2. Mittnacht S. The retinoblastoma protein- from bench to bedside. Eur J Cell Biol 2005; 84:97-107; PMID: 15819393; http://dx.doi.org/10.1016/j.ejcb.2004. 12.012
3. Sherr CJ, McCormick F. The RB and p53 pathways in cancer. Cancer Cell 2002; 2:103-12; http://dx.doi.org/ 10.1016/S1535-6108(02)00102-2
4. Knudsen ES, Knudsen KE. Tailoring to Rb: tumour suppressor status and therapeutic response. Nat Rev Cancer 2008; 8:714-24; PMID:19143056; http://dx. doi.org/10.1038/nrc2401
5. Knudsen ES, Wang JYJ. Targeting the RB-pathway in cancer therapy. Clin Cancer Res 2110; 16:1094-9; PMID:20145169; http://dx.doi.org/10.1158/1078-0432.CCR-09-0787
6. Stone A, Sutherland RL, Musgrove EA. Inhibitors of cell cycle kinases: recent advances and future prospects as cancer therapeutics. Crit Rev in Oncog 2012; 17:175-98; PMID:22471707; http://dx.doi.org/ 10.1615/CritRevOncog.v17.i2.40
7. Sherr CJ. Cancer Cell cycles. Science 1996; 274:1672-7; http://dx.doi.org/10.1126/science.274.5293.1672
8. Jeon HS, Dracheva T, Tang SH, Meerzaman D, Fukuoka J, Shakoori A, Shilo K, Travis WD, Jen J. SMAD6 contributes to patient survival in non-small cell lung cancer and its knockdown reestablishes TGFbeta homeostasis in lung cancer cells. Cancer Res 2008; 68:9686-92; PMID:19047146; http://dx.doi.org/ 10.1158/0008-5472.CAN-08-1083
9. Knudsen KE, Booth D, Naderi S, Sever-Chroneos Z, Fribourg AF, Hunton IC, Feramisco JR, Wang JYJ, Knudsen ES. Rb-dependent S-phase response to DNA damage. Mol Cell Biol 2000; 20:7751-63; PMID: 11003670; http://dx.doi.org/10.1128/MCB.20.20. 7751-7763.2000
10. Payton M, Chung G, Yakowec P, Wong A, Powers D, Xiong L, Zhang N, Leal J, Bush TL, Santora V, et al. Discovery and evaluation of dual cdk1 and cdk2 inhibitors. Cancer Res 2006; 66:4299-308; PMID: 16618755; http://dx.doi.org/10.1158/0008-5472. CAN-05-2507
11. Plastaras JP, Kim SH, Liu YY, Dicker DT, Dorsey JF, McDonough J, Cerniglia G, Rajendran RR, Gupta A, Rustgi AK, et al. Cell Cycle dependent and schedule dependent antitumor effects of sorafenib combined with radiation. Cancer Res 2007; 67:9443-54; PMID:17909054; http://dx.doi.org/10.1158/0008-5472.CAN-07-1473
12. De Leon G, Sherry TC, Krucher NA. Reduced expression of PNUTS leads to activation of Rb-phosphatase and caspase-mediated apoptosis. Cancer Bio Ther 2008; 7: 833-9; PMID:18360108; http://dx.doi.org/ 10.4161/cbt.7.6.5839
13. Dou QP, An B, Will PL. Induction of a retinoblastoma phosphatase by anticancer drugs accompanies p53-independent G1 arrest and apoptosis. PNAS USA 1995; 92:9019-23; PMID:7568064; http://dx.doi.org/ 10.1073/pnas.92.20.9019
14. Popowski M, Ferguson HA, Sion AM, Koller E, Knudsen E, Van Den Berg CL. Stress and IGF-1 differentially control cell fate through mammalian target of rapamycin (mTOR. and retinoblastoma protein (pRb). J Biol Chem 2008; 283:28265-73; PMID:18697743; http://dx.doi.org/10.1074/jbc. M805724200
15. Lentine B, Antonucci L, Hunce R, Edwards J, Marallano V, Krucher NA. Dephosphorylation of threonine-821 of the retinoblastoma tumor suppressor protein (Rb) is required for apoptosis induced by UV and Cdk inhibition. Cell Cycle 2012; 11:3324-30; PMID: 22895174; http://dx.doi.org/10.4161/cc.21693
16. Masselli A, Wang JYJ. Phosphorylation site mutated RB exerts contrasting effects on apoptotic response to different stimuli. Oncogene 2006; 25:1290-8; PMID: 16205627; http://dx.doi.org/10.1038/sj.onc.1209161
17. Taya Y. Rb kinases and Rb binding proteins: new points of view. Trends Biochem Sci 1997; 22:14-7; PMID:9020586; http://dx.doi.org/10.1016/S0968-0004(96)10070-0
18. Burke JR, Deshong AJ, Pelton JG, Rubin SM. Phos-phorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding. J Biol Chem 2010; 285:16286-93; PMID:20223825; http://dx.doi.org/10.1074/jbc. M110.108167
19. Delston RB, Matatall KA, Sun Y, Onken MD, Harbour JW. p38 phosphorylates Rb on Ser567 by a novel, cell cycle-independent mechanism that triggers Rb-Hdm2 interaction and apoptosis. Oncogene 2011; 30:588-99; PMID:20871633; http://dx.doi.org/ 10.1038/onc.2010.442
20. Knudsen ES, Wang JYJ. Differential regulation of retinoblastoma protein function by specific cdk phosphorylation sites. J Biol Chem 1996; 271:8313-20; PMID:8626527; http://dx.doi.org/10.1074/jbc.271. 14.8313
21. Knudsen ES, Wang JYJ. Dual mechanisms for the inhibition of E2F binding to Rb by cyclin-dependent kinase mediated Rb phosphorylation. Mol Cell Bio 1997; 17:5771-83; PMID:9315635
22. Rubin SM, Deciphering the retinoblastoma protein phosphorylation code. Trends Biochem Sci 2013; 38:12-9; PMID:23218751; http://dx.doi.org/10.1016/ j.tibs.2012.10.007
23. Ma D, Zhou P, Harbour JW. Distinct mechanisms for regulating the tumor suppressor and antiapoptotic functions of Rb. J Biol Chem 2003; 278:19358-66; PMID:12646568; http://dx.doi.org/10.1074/jbc. M301761200
24. Agdebola O, Pasternack GR. Phosphorylated retinoblastoma protein complexes with pp32 and inhibits pp32-mediated apoptosis. J Biol Chem 2005; 280:15497-502; PMID:15716273; http://dx.doi.org/ 10.1074/jbc.M411382200
25. Ferecatu I, Le Floch N, Bergeaud M, Rodŕguez-Enfedaque A, Rincheval V, Oliver L, Vallette FM, Mignotte B, Vayssìere J-L. Evidence for a mitochondrial localization of the retinoblastoma Protein. BMC Cell Biol 2009; 10:50; http://dx.doi.org/10.1186/1471-2121-10-50
26. Hilgendorf KI, Leshchiner ES, Nedelcu S, Maynard MA, Calo E, Ianari A, Walensky LD, Lees JA. The retinoblastoma protein induces apoptosis directly at the mitochondria. Genes Dev 2013; 27:1003-15; http:// dx.doi.org/10.1101/gad.211326.112
27. Walensky LD, Gavathiotis E. Bax unleashed: the biochemical transformation of an inactive cytosolic monomer into a mitochondrial pore. Trends Biochem Sci 2011; 36:642-52; PMID:21978892; http://dx.doi.org/ 10.1016/j.tibs.2011.08.009
28. De Leon G, Cavino M, D'Angelo M, Krucher NA. PNUTS knockdown potentiates the apoptotic effect of roscovitine in breast and colon cancer cells. Int J Oncol 2010; 36:1269-75; PMID:20372802
29. Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level Nat Rev Mol Cell Biol 2008; 9:231-41; PMID:18073771; http://dx. doi.org/10.1038/nrm2312
30. Hanahan D, Weinberg RA. The hallmarks of cancer, Cell 2000; 100:57-70.
31. Haas-Kogan D, Kogan SC, Levi D, Dazin P, T'Ang A, Fung Y-KT, Isreal MA. Inhibition of apoptosis by retinoblastoma gene product. EMBO J 1995;14: 461-72.
32. Chau BN, Chen T-T, Wan YY, DeGregori J, Wang JYJ. Tumor necrosis factor alpha-induced apoptosis requires p73 and c-ABL activation downstream of RB degradation. Mol Cel Biol 2004; 24:4438-47; PMID: 15121862; http://dx.doi.org/10.1128/MCB.24.10. 4438-4447.2004
33. Shim J, Park H-S, Kim MJ, Park J, Park E, Cho S-G, Eom S-J, Lee H-W, Joe CO, Choi E-J. Rb protein down-regulates the stress-activated signals through inhibiting c-Jun N-terminal kinasestress-activated protein kinase. J Biol Chem 2000; 275:14107-11; PMID:10799486; http://dx.doi.org/10.1074/jbc.275. 19.14107
34. Shackney SE, Shankey TV. Cell cycle models for molecular biology and molecular oncology: exploring new dimensions. Cytometry 1999; 35:97-116; PMID: 10554165; http://dx.doi.org/10.1002/(SICI)1097-0320(19990201)35:2〈97::AID-CYTO1〉3.0.CO;2-5
35. Rubin SM. Deciphering the retinoblastoma protein phosphorylation code. TIBS 2013; 38:12-9; PMID: 23218751; http://dx.doi.org/10.1016/j.tibs.2012. 10.007
36. Berndt N, Dohadwala M, Liu CWY. Constitutively active protein phosphatase 1α causes Rb-dependent G1 arrest in human cancer cells. Curr Biol 1997; 7:375-86; PMID:9197238; http://dx.doi.org/10.1016/S0960-9822(06)00185-0
37. Wang R-H, Liu CWY, Avramis VI, Berndt N. Protein phosphatase 1α-mediated stimulation of apoptosis is associated with dephosphorylation of the retinoblastoma protein. Oncogene 2001; 20:6111-22; PMID: 11593419; http://dx.doi.org/10.1038/sj.onc.1204829
38. Krucher NA, Zygmunt A, Mazloum N, Tamrakar S, Ludlow JW, Lee YMWT. Interaction of the retinoblastoma protein (pRb) with the catalytic subunit of DNA polymerase δ (p125). Oncogene 2000; 19:5464-70; PMID:11114723; http://dx.doi.org/10.1038/sj.onc. 1203930